Every Single Cell Clones from Cancer Cell Lines Growing Tumors In Vivo May Not Invalidate the Cancer Stem Cell Concept

Por Li, Fengzhi
Publicado em 2009

Anticancer drug FL118 is more than a survivin inhibitor: where is the Achilles’ heel of cancer?

Por Li, Fengzhi
Publicado em 2014

Survivin Study: An Update of “What is the Next Wave?”

Por LI, FENGZHI, LING, XIANG
Publicado em 2006

An intravenous (i.v.) route-compatible formulation of FL118, a survivin, Mcl-1, XIAP, and cIAP2 selective inhibitor, improves FL118 antitumor efficacy and therapeutic index (TI)

Por Ling, Xiang, Li, Fengzhi
Publicado em 2013

New trends for overcoming ABCG2/BCRP-mediated resistance to cancer therapies

Por Westover, David, Li, Fengzhi
Publicado no J Exp Clin Cancer Res (2015)

Role of the SurvivinGene in Pathophysiology

Por Li, Fengzhi, Brattain, Michael G.
Publicado em 2006

Transcriptional and posttranscriptional controls of survivin in cancer cells: Essential interfaces for developing novel approaches for cancer treatment

Por Zhang, Mengjie, Yang, Jie, Li, Fengzhi
Publicado em 2006

Forced Expression of Survivin-2B Abrogates Mitotic Cells and Induces Mitochondria-dependent Apoptosis by Blockade of Tubulin Polymerization and Modulation of Bcl-2, Bax, and Surviv...

Por Ling, Xiang, Cheng, Qiuying, Black, Jennifer D., Li, Fengzhi
Publicado em 2007

Survivin repression by p53, Rb, and E2F2 in normal human melanocytes

Por Raj, Deepak, Liu, Tong, Samadashwily, George, Li, Fengzhi, Grossman, Douglas
Publicado em 2007

Auto-inhibitory Mechanism of the Human Mitochondrial RNase P Protein Complex

Por Li, Fengzhi, Liu, Xiaofen, Zhou, Weihong, Yang, Xue, Shen, Yuequan
Publicado no Sci Rep (2015)

Nuclear or cytoplasmic expression of survivin: What is the significance?

Por Li, Fengzhi, Yang, Jie, Ramnath, Nithya, Javle, Milind M., Tan, Dongfeng
Publicado em 2005

Transcriptional inhibition of p21 (WAF1/CIP1) gene (CDKN1) expression by survivin is at least partially p53-dependent: Evidence for survivin acting as a transcription factor or co-...

Por Tang, Lei, Ling, Xiang, Liu, Wensheng, Das, Gokul M., Li, Fengzhi
Publicado no Biochem Biophys Res Commun (2012)

Cancer cell sensitivity to bortezomib is associated with survivin expression and p53 status but not cancer cell types

Por Chanan-Khan Asher A, Calinski Diane, Ling Xiang, Zhou Muxiang, Li Fengzhi
Publicado em 2010-01-01

Induction of Cell Cycle Arrest by Human T-Cell Lymphotropic Virus Type 1 Tax in Hematopoietic Progenitor (CD34(+)) Cells: Modulation of p21(cip1/waf1) and p27(kip1) Expression

Por Tripp, Adam, Banerjee, Prabal, Sieburg, Michelle, Planelles, Vicente, Li, Fengzhi, Feuer, Gerold
Publicado em 2005

Molecular mechanism of upregulation of survivin transcription by the AT-rich DNA-binding ligand, Hoechst33342: evidence for survivin involvement in drug resistance

Por Wu, Jianguo, Apontes, Pasha, Song, Lei, Liang, Ping, Yang, Lily, Li, Fengzhi
Publicado em 2007

Cancer cell sensitivity to bortezomib is associated with survivin expression and p53 status but not cancer cell types

Por Ling, Xiang, Calinski, Diane, Chanan-Khan, Asher A, Zhou, Muxiang, Li, Fengzhi
Publicado em 2010

FL118 Induces p53-Dependent Senescence in Colorectal Cancer Cells by Promoting Degradation of MdmX

Por Ling, Xiang, Xu, Chao, Fan, Chuandong, Zhong, Kai, Li, Fengzhi, Wang, Xinjiang
Publicado no Cancer Res (2014)

The structure of WbnH in a near active state

Por Li, Fengzhi, Li, Siwei, Liu, Xiaofen, Yang, Xue, Wang, Peng, Shen, Yuequan
Publicado no Protein Cell (2015)

FL118, a novel camptothecin analogue, overcomes irinotecan and topotecan resistance in human tumor xenograft models

Por Ling, Xiang, Liu, Xiaojun, Zhong, Kai, Smith, Nicholas, Prey, Joshua, Li, Fengzhi
Publicado no Am J Transl Res (2015)

Enhancing effectiveness of the MDR-sensitive compound T138067 using advanced treatment with negative modulators of the drug-resistant protein survivin

Por Ling, Xiang, He, Xiang, Apontes, Pasha, Cao, Felicia, Azrak, Rami G., Li, Fengzhi
Publicado em 2009